Blue Earth Diagnostics

Blue Earth Diagnostics Limited is a molecular imaging company developing and commercialising PET radiopharmaceuticals for cancer diagnosis and treatment planning.

The company serves clinicians, healthcare systems and patients by providing administered imaging agents that support clinical decision making in oncology.

Its work focuses on cancer-focused radiopharmaceutical technologies, including approved products and pipeline candidates intended to improve detection, staging and management of serious disease.